Merck & Co MRK
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 95th percentile, 5-year average 76.1x
#2856 of 2972 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 99th percentile, 5-year average 6.0x
#4831 of 5311 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 98th percentile, 5-year average 4.3x
#4003 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 8.80 | – | 6.05 | 99% (pricier than usual) | #4831 of 5311 (1 = cheapest) |
| PE | 151.03 | 22.42 | 76.09 | 95% (pricier than usual) | #2856 of 2972 (1 = cheapest) |
| PS | 5.47 | 5.40 | 4.34 | 98% (pricier than usual) | #4003 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on MRK.
Sign in to join the discussion.